Downloadcenter
Annual report
.
Half year report
.
Annual General Meeting
.
.
- Sustainability report 2019
- Sustainability report 2019 in brief
- Sustainability report 2018
- Sustainability report 2017
- Combined financial statements of the Galenica Group 2014 - 2016
- Code of conduct of the Galenica Group
- Supplier code of conduct
- Structure (as of 1.1.2021)
- Leadership organisation (as of 1.1.2021)
Presentations
.
- Investor Presentation (Version August 2020)
- Analyst Consensus September 2020
- Analyst Consensus July 2020
- Analyst Consensus April 2020
- March 2020 version: Investor Presentation
- 10 March 2020, Jean-Claude Clémençon, CEO: Successful and sustainable development
- 10 March 2020, Felix Burkhard, CFO: Annual financial statements 2019
- 10 March 2020, Daniele Madonna, Head Retail Business sector: Omni-channel & omni-care
- Sales and Guidance Update
- August 2019 version: Investor Presentation
- April 2019 version: Investor Presentation
- 12 March 2019, Jean-Claude Clémençon, CEO: Strategic positioning of Galenica
- 12 March 2019, Felix Burkhard, CFO: Annual financial statements 2018
- 12 March 2019, Thomas Szuran, Head Products & Brands Business sector: Our potential in the Swiss Consumer Healthcare market
- 12 March 2019, Daniele Madonna, Head of Retail Business sector: Omni-Channel
- January 2019 version: Investor Presentation
- 7 August 2018: H1 results 2018
- August 2018 version: Investor Presentation
- 13 March 2018, J.-C. Clémençon, CEO: 1 year after the IPO
- 13 March 2018, F. Burkhard, CFO: Annual financial statements 2017
- 13 March 2018, D. Madonna: Digitalisation in Retail
- 13 March 2018, T. de Coverly Veale: A new beginning for Vifor Consumer Health
- 13 March 2018, C. Amstutz: Documedis®
- March 2018 version: Investor Presentation
- 14 March 2017, E. Jornod, Galenica – Galenica Group – Vifor Pharma Group
- 14 March 2017, J. Kneubühler, IPO of Galenica Santé: a new chapter in our history
- 14 March 2017, C. Bond, Results 2016 of Vifor Pharma
- 14 March 2017, J.-C. Clémençon, Galenica Santé - Our commitment to provide Swiss healthcare provision
- 14 March 2017, S. Schulze, Vifor Pharma - Leading portfolio and mid-term growth drivers
